FRI0532 Dual energy x-ray absorptiometry testing in women with breast cancer initiating therapy with aromatase inhibitors reduces subsequent fracture risk
FRI0532 Dual energy x-ray absorptiometry testing in women with breast cancer initiating therapy with aromatase inhibitors reduces subsequent fracture risk